IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 2102 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  Search
 
  
Resource Links
 »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »  Article in PDF (737 KB)
 »  Citation Manager
 »  Access Statistics
 »  Reader Comments
 »  Email Alert *
 »  Add to My List *
* Registration required (free)

 
In This Article
 »  Abstract
 » Introduction
 »  Materials and Me...
 » Results
 » Discussion
 »  References
 »  Article Figures

 Article Access Statistics
    Viewed1870    
    Printed39    
    Emailed0    
    PDF Downloaded111    
    Comments [Add]    

Recommend this journal

 


 
 Table of Contents    
SHORT COMMUNICATION
Year : 2015  |  Volume : 47  |  Issue : 4  |  Page : 447-450
 

Anti-inflammatory activity of Nerium indicum by inhibition of prostaglandin E2 in murine splenic lymphocytes


Department of Zoology, Cellular Immunology Laboratory, University of North Bengal, Siliguri, West Bengal, India

Date of Submission10-Feb-2015
Date of Decision16-Jun-2015
Date of Acceptance25-Jun-2015
Date of Web Publication21-Jul-2015

Correspondence Address:
Prof. Tapas Kumar Chaudhuri
Department of Zoology, Cellular Immunology Laboratory, University of North Bengal, Siliguri, West Bengal
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0253-7613.161275

Rights and Permissions

 » Abstract 

Objective: Nerium indicum Mill (syn. N. oleander L. and N. odorum Aiton; family: Apocynaceae) is a medicinal plant, used in the treatment of diverse ailments including various chronic inflammatory diseases in traditional medicine. We have previously demonstrated the immunomodulatory activity of a bioactive fraction of Nerium indicum leaf (NILE) by studying up-regulation of interleukin-2 (IL-2), IL-10, interferon-gamma and down regulation of IL-4, tumor necrosis factor-alpha (TNF-α), nitric oxide, cyclooxygenase-1 (COX-1) and COX-2 activities. Therefore, this study aimed to confirm the anti-inflammatory activity of NILE by inhibition of prostaglandin E 2 (PGE 2 ) activity in murine splenic lymphocytes in vitro.
Materials and Methods: Murine lymphocytes were isolated from spleen and stimulated with 5 ΅g/mL concanavalin A in RPMI-1640, supplemented with 50 U/mL penicillin, 50 U/mL streptomycin, 50 U/mL nystatin and 10% fetal bovine serum. Different concentrations (0-80 μg/mL) of NILE were added and the cells were cultured for 48 h. The culture supernatants were thereafter collected by centrifugation and assayed for expression of PGE 2 level. The data were analyzed statistically.
Results: The results demonstrated a 2.26-fold inhibition of PGE 2 level at 80 μg/mL of NILE. Half maximum inhibitory concentration (IC 50 ) was calculated to be 44.95 ± 0.45 ΅g/mL. Linear correlation analysis of the dose-dependent PGE 2 inhibition with other pro- and anti-inflammatory mediators demonstrated high inter-correlation between the parameters.
Conclusions: Thus, the present study remains in accordance with our previous report and confirms the anti-inflammatory claim of N. indicum, mentioned in the traditional medicine.


Keywords: Anti-inflammatory, cyclooxygenase, lymphocyte, nerium, prostaglandin


How to cite this article:
Dey P, Chaudhuri TK. Anti-inflammatory activity of Nerium indicum by inhibition of prostaglandin E2 in murine splenic lymphocytes. Indian J Pharmacol 2015;47:447-50

How to cite this URL:
Dey P, Chaudhuri TK. Anti-inflammatory activity of Nerium indicum by inhibition of prostaglandin E2 in murine splenic lymphocytes. Indian J Pharmacol [serial online] 2015 [cited 2019 Sep 22];47:447-50. Available from: http://www.ijp-online.com/text.asp?2015/47/4/447/161275



 » Introduction Top


The fascinating medicinal potential of Nerium indicum in the treatment of diverse immunological conditions such as inflammation, has been mentioned in Indian [1],[2] and Chines [3],[4] traditional medicinal systems. However, in vitro and in vivo studies of the therapeutic potentiality of N. indicum was only confined within the anti-cancer properties of the plant. [5],[6] Study confirming the anti-inflammatory activity of N. indicum has not yet been done by investigating the terminal prostaglandins (PG) responsible for the sensitization phase of inflammation. Previously, Müller et al., [7] demonstrated the stimulation of macrophage mediated cytotoxic activity by polysaccharides of Nerium indicum leaves (NILE). Moreover, very recently we have showed that a bioactive hydro-methanolic fraction of NILE up-regulates interleukin-2 (IL-2), IL-10, interferon-gamma and down-regulates tumor necrosis factor-alpha (TNF-α), IL-4, nitric oxide (NO) apart from the inhibition of cyclooxygenase (COX) activity in murine splenic lymphocytes in vitro.[8] Moreover, the bioactive fraction also demonstrated potent antioxidant and fee radical scavenging activity. [9]

Therefore, in the present study we have demonstrated the potential of the 70% hydro-methanolic extract of NILE to inhibit the prostaglandin E 2 (PGE 2 ) level on murine splenic lymphocytes using enzyme immuno-assay.


 » Materials and Methods Top


Chemicals

All reagents were procured from HiMedia Laboratories Pvt., Ltd., (Mumbai, India), otherwise indicated. Nystatin and concanavalin A (Con A) were obtained from Sigma-Aldrich (USA). PGE 2 enzyme immuno-assaykit was purchased from Cayman Chemical Company (An Arbor, MI, USA).

Plant Material and Extract Preparation

White flower variety of N. indicum plant was collected from the University of North Bengal Campus, India (26.71 o N, 88.35 o S) and identified by taxonomist Prof. A. P. Das of Department of Botany, University of North Bengal. A voucher specimen was stored in the herbarium of Department of Botany (accession number of 09618).

The leaves were washed with double distilled water to remove dirt and shade dried at room temperature for 20 days, followed by grinding to powder. The powder (50 g) was mixed with 100% methanol (500 mL) with continuous shaking (160 rpm) for 20 h at 37°C. The mixture was filtered and then centrifuged at 2850 × g for 15 min. The pellet was again mixed with 100% methanol (500 mL) and re-processed as previously described. The supernatants were collected from both the phases, filtered and the filtrate was concentrated under reduced pressure in a rotary evaporator. The resultant NILE extract was lyophilized and stored at −20°C until further use.

Maintenance of Animals

Swiss albino mice (30 ± 2 g of body weight) of 6-8 weeks were used for the following studies. Animals were maintained under standard laboratory conditions in the animal house of the Department of Zoology, University of North Bengal with food and water ad libitum under a constant 12 h photoperiod (temperature 25 ± 2°C). Animal Ethical Committee approval of University of North Bengal (No. 840/ac/04/Committee for the Purpose of Control and Supervision of Experiments on Animals) was taken prior to the experiments.

Culture of Splenocytes

Spleen was removed aseptically from Swiss albino mice under proper anesthesia and washed with RPMI-1640 to remove blood. The spleen was passed through the mesh of a tissue grinder and then splenocyte suspension was prepared in RPMI-1640. The splenocytes were washed (200 × g) thrice using RPMI-1640 for 10 min and resuspended in 1N NH 4 Cl to lyse red blood cells. After 5 min ice cold RPMI-1640 was added to stop the reaction. The cells were again centrifuged (200 × g) and resuspended in RPMI-1640. Splenocytes were adjusted as 2 × 10 6 cells/mL with RPMI-1640, supplemented with 50 U/mL penicillin, 50 U/mL streptomycin, 50 U/mL nystatin and 10% fetal bovine serum and seeded into 6-well culture plates. Con A was added to get a final concentration of 5 μg/mL and 100 μL of different concentrations of NILE (0-80 μg/mL) was then added to the wells. Control did not receive Con A and NILE. The plates were then covered and incubated under 5% CO 2 and humidified atmosphere of 90% air at 37°C temperature for 48 h.

After incubation, culture supernatants from each well were centrifuged at 2850 × g for 10 min. The supernatants were used to assay PGE 2 levels.

Measurement of Prostaglandin E 2 Level

PGE 2 was measured by competitive binding between PGE 2 and PGE 2 -acetylcholineesterase (PGE 2 -AChE) for restricted amount of PGE 2 monoclonal antibody using PGE 2 EIA Kit (Cayman) according to the manufacturer's instructions. In brief, 50 μL cell culture supernatants were added to the respective wells of a 96-well plate, precoated with goat polyclonal anti-mouse IgG, followed by 50 μL of PGE 2 -AChE tracer and 50 μL PGE 2 monoclonal antibody. The plate was incubated for 18 h at 4°C and then washed five times with wash buffer. Ellman's reagent (200 μL) was added and incubated in dark for 60 min with constant mild shaking. Then, absorbance was read at 415 nm using Bio-Rad iMark™ microplate absorbance reader. Standard curve of PGE 2 was prepared in parallel to the samples.

Data Analysis and Statistics

All data are reported as the mean ± standard deviation of six measurements. Comparisons between the control group and the test groups were performed by one-way analysis of variance and group comparisons for percentage of inhibition were performed by paired t-test susing KyPlot version 2.0 (KyensLab Inc.,) beta 15 (32 bit) for windows. P < 0.05 was considered significant. Linear correlation analysis were performed using Microsoft Excel 2010 (Microsoft Corporation).


 » Results Top


Inhibition of Prostaglandin E 2

This study demonstrated that NILE has the potentiality to inhibit PGE 2 synthesis in murine splenic lymphocytes [Figure 1]. PGE 2 level was increased to 649.30 ± 44.6 pg/mL (4.6-fold increase compared to control) due to stimulation with Con A, which upon NILE treatment at 80 μg/mL, was significantly down-regulated (P < 0.001) to 286.06 ± 26.75 pg/mL (2.26-fold decrease compared to 0 μg/mL). The percentage of inhibition (inhibitory concentration was 44.95 ± 0.45 μg/mL) of PGE 2 is presented in [Figure 2]. This demonstrated in vitro dose-dependent activity of NILE to inhibit PGE 2 levels.
Figure 1: Levels (pg/mL) of prostaglandin E2 under different doses (0-80 μg/mL) of Nerium indicum leaf. Data are represented as mean ± standard deviation of six observations. ***P < 0.001 compared to control. β = P < 0.01 and α = P < 0.001 versus 0 μg/mL group

Click here to view
Figure 2: Percentage of inhibition of prostaglandin E2 under different doses (0-80 μg/mL) of Nerium indicum leaf. Data are represented as mean ± standard deviation of six observations. ***P < 0.001 compared to 0 μg/mL group

Click here to view


Correlation Analysis

The linear correlation analysis between the PGE 2 level with different pro- and anti-inflammatory signals are demonstrated in [Figure 3]. High positive correlation between PGE 2 level with COX-1 (R΂ =0.6238) and COX-2 activities (R΂ =0.6014). The highest degree of correlation resided between PGE 2 and IL-2 level (R2 =0.895).
Figure 3: Correlation of prostaglandin E2 level with the expression of different pro- and anti-inflammatory mediators. Axes "x" and "y" denotes correlation points of respective parameters measured at pg/mL at different dose of Nerium indicum leaf (0-80 μg/mL). Where, R2 = coefficient of determination

Click here to view



 » Discussion Top


The complex scenario of chronic inflammation is primarily governed by the fine balance between pro- and anti-inflammatory cytokines and formation of arachidonic metabolites through the enzymatic cascade of COX. COX-1 is constitutively expressed, whereas COX-2, the inducible isoform, is predominantly involved in chronic inflammation. PG are metabolites of arachidonic acid, generated through a enzymatic cascade of COX and PG synthase, which leads to the cardinal signs of inflammation, that is, redness due to increase in blood flow, swelling due to vasodilation and pain due to induction of peripheral sensory neurons. [10] PG are the terminal mediators of hyperalgesia, generation of fever, increase in vascular permeability as well as primarily responsible for vascular diseases and angiogenesis. COX inhibitors are therefore routinely used as therapeutics to inhibit PG synthesis to eliminate inflammation in a wide range of diseases. [11]

The plant lectin Con A originated from Canavalia brasiliensis Benth is a potent T-lymphocyte polyclonal activator [12] and also a potent mediator of chronic inflammation through janus kinase/signal transducers and activators of transcription three pathway. [13] In the present study, murine splenic lymphocytes were stimulated using an optimum dose of Con A (0 μg/mL) to generate a local plethora of inflammatory mediators such as PGE 2 . As a result, the PGE 2 level was increased 4.60-fold from nonstimulated control to Con A stimulated 0 μg/mL. Dose-dependent decrease in PGE 2 was evident with the increase in the NILE concentration, which resulted in 2.26-fold decrease at 80 μg/mL compared to 0 μg/mL group. The pattern of dose-dependent PGE 2 inhibition directly corroborates the inhibition of COX-1 and COX-2 activities as demonstrated in our previous study. [8]

PGE 2 is a potent inhibitor of IL-2 without any killing of IL-2 expressing cells. [14] Wolf et al., [15] reported that PGE 2 inhibits IL-2 expression only at sub-optimal stimulation by Con A (<5 μg/mL). However, the dose-dependent negative-linear correlation analysis in the present study demonstrated very high correlation (R΂ =0.895) between IL-2 and PGE 2 level [Figure 2] reflecting on the fact that PGE 2 level had serious implications on the IL-2 expression in the lymphocytes. Besides, the high positive correlation of PGE 2 with the pro-inflammatory mediators such as NO (R 2 = 0.7866) and TNF-α (R 2 = 0.8797) and anti-inflammatory cytokine IL-10 (R 2 = 0.876) reflect the anti-inflammatory effect of NILE.

There are numerous reports on the anti-cancer activities of various fractions and compounds from N. indicum. However, there were only few studied demonstrating the immunomodulatory activity of the plant in spite of the fact that the plant is extensively used in traditional medicine. Müller et al., [7] demonstrated the macrophage-mediated mild cytotoxic activity of a polysaccharide fraction of NILE. A glycoside oleandrin, isolated from the leaves showed potent nuclear factor kβ activation inhibitory activity. [16],[17] Thus, in continuation to our previous study, here we demonstrate the potent anti-inflammatory activity of N. indicum by the inhibition of PGE 2 expression in Con A stimulated murine lymphocytes, which is possibly due to the inhibition of COX activities responsible for production of PGE 2 .

Financial Support and Sponsorship

Nil.

Conflicts of Interest

There are no conflicts of interest.

 
 » References Top

1.
Dastur JF. Medicinal Plants of India and Pakistan. Bombay, India: DB Taraporevala Sons and Co Ltd.; 1962.  Back to cited text no. 1
    
2.
Khare CP. Indian Medicinal Plants: An Illustrated Dictionary. India: Springer; 2007.  Back to cited text no. 2
    
3.
Ding K, Fang JN, Dong T, Tsim KW, Wu H. Characterization of a rhamnogalacturonan and a xyloglucan from neriumindicum and their activities on PC12 pheochromocytoma cells. J Nat Prod 2003;66:7-10.  Back to cited text no. 3
    
4.
Ji YB. Pharmacological action and application of anticancer traditional Chinese medicine. Heilongjiang, China: Heilongjiang Science Press; 1999.  Back to cited text no. 4
    
5.
Pathak S, Multani AS, Narayan S, Kumar V, Newman RA. Anvirzel, an extract of Nerium oleander, induces cell death in human but not murine cancer cells. Anticancer Drugs 2000;11:455-63.  Back to cited text no. 5
    
6.
Apostolou P, Toloudi M, Chatziioannou M, Ioannou E, Knocke DR, Nester J, et al. Anvirzel™ in combination with cisplatin in breast, colon, lung, prostate, melanoma and pancreatic cancer cell lines. BMC Pharmacol Toxicol 2013;14:18.  Back to cited text no. 6
[PUBMED]    
7.
Müller BM, Rosskopf F, Paper DH, Kraus J, Franz G. Polysaccharides from Nerium oleander: Structure and biological activity. Pharmazie 1991;46:657-63.  Back to cited text no. 7
    
8.
Dey P, Chaudhuri TK. Immunomodulatory activity of Nerium indicum through inhibition of nitric oxide and cyclooxygenase activity and modulation of TH1/TH2 cytokine balance in murine splenic lymphocytes. Cytotechnology 2014. DOI: 10.1007/s10616-014-9826-9 [In Press].  Back to cited text no. 8
    
9.
Dey P, Chaudhuri D, Chaudhuri TK, Mandal N. Comparative assessment of the antioxidant activity and free radical scavenging potential of different parts of Nerium indicum. Int J Phytomed 2012;4:54-69.  Back to cited text no. 9
    
10.
Phipps RP, Stein SH, Roper RL. A new view of prostaglandin E regulation of the immune response. Immunol Today 1991;12:349-52.  Back to cited text no. 10
    
11.
Chizzolini C, Brembilla NC. Prostaglandin E2: Igniting the fire. Immunol Cell Biol 2009;87:510-1.  Back to cited text no. 11
    
12.
Andrade JL, Arruda S, Barbosa T, Paim L, Ramos MV, Cavada BS, et al. Lectin-induced nitric oxide production. Cell Immunol 1999;194:98-102.  Back to cited text no. 12
    
13.
Akla N, Pratt J, Annabi B. Concanavalin-A triggers inflammatory response through JAK/STAT3 signalling and modulates MT1-MMP regulation of COX-2 in mesenchymal stromal cells. Exp Cell Res 2012;318:2498-506.  Back to cited text no. 13
    
14.
Chouaib S, Chatenoud L, Klatzmann D, Fradelizi D. The mechanisms of inhibition of human IL 2 production. II. PGE2 induction of suppressor T lymphocytes. J Immunol 1984;132:1851-7.  Back to cited text no. 14
    
15.
Wolf M, Falk W, Männel D, Dröge W. Inhibition of interleukin 2 production by prostaglandin E2 is not absolute but depends on the strength of the stimulating signal. Cell Immunol 1985;90:190-5.  Back to cited text no. 15
    
16.
Manna SK, Sah NK, Newman RA, Cisneros A, Aggarwal BB. Oleandrin suppresses activation of nuclear transcription factor-kappaB, activator protein-1, and c-Jun NH2-terminal kinase. Cancer Res 2000;60:3838-47.  Back to cited text no. 16
    
17.
Sreenivasan Y, Sarkar A, Manna SK. Oleandrin suppresses activation of nuclear transcription factor-kappa B and activator protein-1 and potentiates apoptosis induced by ceramide. Biochem Pharmacol 2003;66:2223-39.  Back to cited text no. 17
    


    Figures

  [Figure 1], [Figure 2], [Figure 3]



 

Top
Print this article  Email this article
 

    

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow